Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pichler

Showing results (201-210 of 323) with videos related to

Pageof 33
Sort By:
Frontiers in Immunology|April 3, 2023
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinomaRenate Pichler, Peter J Siska, Piotr Tymoszuk, et al.
Urologic Oncology|May 8, 2019
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation studyGeorg C Hutterer, Florian Posch, Lorenz Buser, et al.
Cancer Medicine|January 11, 2026
Clinical Significance and Therapeutic Potential of Long Non-Coding RNA H19 in Soft Tissue SarcomaStephan Jahn, Katarina Krajina, Maria Anna Smolle, et al.
RNA Biology|December 5, 2022
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon responseFelix Prinz, Katharina Jonas, Amar Balihodzic, et al.
Cancer Medicine|July 1, 2023
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatmentMatthäus Majewski, Pia Paffenholz, Christian Ruf, et al.
Cancer Medicine|June 16, 2020
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsDominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, et al.
Oncotarget|November 3, 2023
Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinaseRecep Bayraktar, Martin Pichler, Pinar Kanlikilicer, et al.
Wiener Klinische Wochenschrift|August 23, 2018
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysisEva Asamer, Joanna Szkandera, Paul Gibiser, et al.
Stroke|November 4, 2006
C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention StudyReinhold Schmidt, Helena Schmidt, Martin Pichler, et al.
Journal of Photochemistry and Photobiology. B, Biology|March 8, 2013
Comprehensive analysis of alterations in the miRNome in response to photodynamic treatmentDoris Bach, Julia Fuereder, Michael Karbiener, et al.
Pageof 33

Showing results (201-210 of 323) with videos related to

Sort By:
Pageof 33
Frontiers in Immunology|April 3, 2023
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinomaRenate Pichler, Peter J Siska, Piotr Tymoszuk, et al.
Urologic Oncology|May 8, 2019
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation studyGeorg C Hutterer, Florian Posch, Lorenz Buser, et al.
Cancer Medicine|January 11, 2026
Clinical Significance and Therapeutic Potential of Long Non-Coding RNA H19 in Soft Tissue SarcomaStephan Jahn, Katarina Krajina, Maria Anna Smolle, et al.
RNA Biology|December 5, 2022
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon responseFelix Prinz, Katharina Jonas, Amar Balihodzic, et al.
Cancer Medicine|July 1, 2023
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatmentMatthäus Majewski, Pia Paffenholz, Christian Ruf, et al.
Cancer Medicine|June 16, 2020
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsDominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, et al.
Oncotarget|November 3, 2023
Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinaseRecep Bayraktar, Martin Pichler, Pinar Kanlikilicer, et al.
Wiener Klinische Wochenschrift|August 23, 2018
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysisEva Asamer, Joanna Szkandera, Paul Gibiser, et al.
Stroke|November 4, 2006
C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention StudyReinhold Schmidt, Helena Schmidt, Martin Pichler, et al.
Journal of Photochemistry and Photobiology. B, Biology|March 8, 2013
Comprehensive analysis of alterations in the miRNome in response to photodynamic treatmentDoris Bach, Julia Fuereder, Michael Karbiener, et al.
Pageof 33